Compare FENC & ZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FENC | ZH |
|---|---|---|
| Founded | 1996 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.4M | 295.1M |
| IPO Year | 2010 | 2021 |
| Metric | FENC | ZH |
|---|---|---|
| Price | $6.50 | $3.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | 133.5K | ★ 376.8K |
| Earning Date | 05-12-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $44,642,000.00 | N/A |
| Revenue This Year | $65.12 | N/A |
| Revenue Next Year | $41.08 | N/A |
| P/E Ratio | ★ N/A | $20.74 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.65 | $2.57 |
| 52 Week High | $9.92 | $5.55 |
| Indicator | FENC | ZH |
|---|---|---|
| Relative Strength Index (RSI) | 47.05 | 44.73 |
| Support Level | $5.65 | $3.05 |
| Resistance Level | $8.09 | $3.82 |
| Average True Range (ATR) | 0.34 | 0.16 |
| MACD | 0.04 | -0.05 |
| Stochastic Oscillator | 48.51 | 6.80 |
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Zhihu Inc is engaged in the operation of one online content community which monetizes through paid membership services, marketing services and other services in the People's Republic of China. It is an online content community where people come to find solutions, make decisions, seek inspiration, and have fun. Its community supports discussions ranging from everyday consumer decisions, such as purchasing products or planning travel, to more specialized areas on professional knowledge, technological developments including artificial intelligence and academic topics. It operates in single segment and its revenues are derived from within the PRC.